| Michael Scott Bergman, CRNA | |
|
7601 Southcrest Pkwy, Southaven, MS 38671-4739 | |
| (662) 349-4000 | |
| Not Available |
| Full Name | Michael Scott Bergman |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 18 Years |
| Location | 7601 Southcrest Pkwy, Southaven, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972517977 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kadlec Regional Medical Center | Richland, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Premier Anesthesia Of Richland A Division Of Premier Anesthesia, Llc | 4880699172 | 56 |
News Archive
French researchers have reported the strongest proof yet that evidence of 'circulating tumor cells' found in samples of a patient's blood is strongly linked to poor outcomes such as a short time to disease progression.
Discussing the meeting of G20 leaders taking place this week in Los Cabos, Mexico, the Financial Times states, "Food security, long only a concern for aid advocates and farming ministers, is now hotly debated among G20 leaders."
While some youth experiment with marijuana but don't go on to long-term use, others develop a problematic pot habit that continues into adulthood.
Scientists have found that overexpression of a protein called Down Syndrome Critical Region 1 (DSCR-1) blocks the formation of new blood vessels and thus reduces tumor growth. Therapeutics based on this finding may potentially lead to new cancer treatments.
Acceleron Pharma, a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it has been awarded a $1.5 million grant from the Muscular Dystrophy Association to support clinical studies of ACE-031 in Duchenne Muscular Dystrophy, a disabling neuromuscular disease in which patients experience a progressive loss of muscle mass and strength.
› Verified 3 days ago
| Entity Name | Public Hospital District No 3 Of Whitman County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922009448 PECOS PAC ID: 7719875020 Enrollment ID: O20040309000090 |
News Archive
French researchers have reported the strongest proof yet that evidence of 'circulating tumor cells' found in samples of a patient's blood is strongly linked to poor outcomes such as a short time to disease progression.
Discussing the meeting of G20 leaders taking place this week in Los Cabos, Mexico, the Financial Times states, "Food security, long only a concern for aid advocates and farming ministers, is now hotly debated among G20 leaders."
While some youth experiment with marijuana but don't go on to long-term use, others develop a problematic pot habit that continues into adulthood.
Scientists have found that overexpression of a protein called Down Syndrome Critical Region 1 (DSCR-1) blocks the formation of new blood vessels and thus reduces tumor growth. Therapeutics based on this finding may potentially lead to new cancer treatments.
Acceleron Pharma, a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it has been awarded a $1.5 million grant from the Muscular Dystrophy Association to support clinical studies of ACE-031 in Duchenne Muscular Dystrophy, a disabling neuromuscular disease in which patients experience a progressive loss of muscle mass and strength.
› Verified 3 days ago
| Entity Name | Premier Anesthesia Of Richland A Division Of Premier Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013940253 PECOS PAC ID: 4880699172 Enrollment ID: O20060920000047 |
News Archive
French researchers have reported the strongest proof yet that evidence of 'circulating tumor cells' found in samples of a patient's blood is strongly linked to poor outcomes such as a short time to disease progression.
Discussing the meeting of G20 leaders taking place this week in Los Cabos, Mexico, the Financial Times states, "Food security, long only a concern for aid advocates and farming ministers, is now hotly debated among G20 leaders."
While some youth experiment with marijuana but don't go on to long-term use, others develop a problematic pot habit that continues into adulthood.
Scientists have found that overexpression of a protein called Down Syndrome Critical Region 1 (DSCR-1) blocks the formation of new blood vessels and thus reduces tumor growth. Therapeutics based on this finding may potentially lead to new cancer treatments.
Acceleron Pharma, a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it has been awarded a $1.5 million grant from the Muscular Dystrophy Association to support clinical studies of ACE-031 in Duchenne Muscular Dystrophy, a disabling neuromuscular disease in which patients experience a progressive loss of muscle mass and strength.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Scott Bergman, CRNA 929 Fallen Oaks Dr, Collierville, TN 38017-3540 Ph: (901) 853-2336 | Michael Scott Bergman, CRNA 7601 Southcrest Pkwy, Southaven, MS 38671-4739 Ph: (662) 349-4000 |
News Archive
French researchers have reported the strongest proof yet that evidence of 'circulating tumor cells' found in samples of a patient's blood is strongly linked to poor outcomes such as a short time to disease progression.
Discussing the meeting of G20 leaders taking place this week in Los Cabos, Mexico, the Financial Times states, "Food security, long only a concern for aid advocates and farming ministers, is now hotly debated among G20 leaders."
While some youth experiment with marijuana but don't go on to long-term use, others develop a problematic pot habit that continues into adulthood.
Scientists have found that overexpression of a protein called Down Syndrome Critical Region 1 (DSCR-1) blocks the formation of new blood vessels and thus reduces tumor growth. Therapeutics based on this finding may potentially lead to new cancer treatments.
Acceleron Pharma, a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it has been awarded a $1.5 million grant from the Muscular Dystrophy Association to support clinical studies of ACE-031 in Duchenne Muscular Dystrophy, a disabling neuromuscular disease in which patients experience a progressive loss of muscle mass and strength.
› Verified 3 days ago
Jonathan Wesley Reed, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7601 Southcrest Pkwy, Southaven, MS 38671 Phone: 662-772-4333 | |
Jesse Clements, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 391 Southcrest Cir Ste 108, Southaven, MS 38671 Phone: 901-484-8313 | |
Robert Lawrence Ryan, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 7580 Clarington Cv, Southaven, MS 38671 Phone: 662-349-9136 Fax: 662-349-0677 | |
Steven Keith Owens, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7601 Southcrest Pkwy, Southaven, MS 38671 Phone: 662-349-2659 Fax: 662-349-2653 | |
Nikkita Shanee Robinson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7601 Southcrest Pkwy, Southaven, MS 38671 Phone: 662-772-4333 Fax: 855-999-1345 | |
Morgan Thomas Smith, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 391 Southcrest Cir Ste 108, Southaven, MS 38671 Phone: 662-349-2659 | |
Angela D. Mccoy, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7601 Southcrest Pkwy, Southaven, MS 38671 Phone: 662-772-4333 Fax: 334-244-1830 |